Radiocontrast interference in screening tests for genetic-metabolic diseases.
Screening tests for genetic metabolic diseases remain extremely useful due to their rapidity, ease of interpretation and substantial reduction of cost. However, interferences in these tests are still a source of concern in laboratory medicine. Cost considerations have so compressed the duration of the medical work-up that the administration of radiologic contrast may often antedate the collection of body fluids for genetic-metabolic testing. It has been found that under these circumstances, certain contrast media may interfere with the urinary studies of amino acids, organic acids, and tests involving ultraviolet absorption such as those concerned with purines, pyrimidines, and related compounds. The consequences of interference may be misdiagnosis, repeated testing, extensive and expensive work-ups, and unnecessary delay and anxiety for the family. As in all testing, it is prudent to avoid medications and atypical diets, if possible. In the case of contrast media, it is a simple matter to collect samples for analysis prior to the administration of radiocontrast so as to avoid the pitfalls and yet not delay the diagnostic work-up.
Potter
J L
JL
Department of Pathology and Laboratory Medicine, The Children's Hospital Medical Center of Akron, OH, USA.
Timmons
G D
GD
Kofron
W G
WG
D016477:Artifacts; D002854:Chromatography, Paper; D003287:Contrast Media / Q000009:adverse effects*; D004591:Electrophoresis, Polyacrylamide Gel; D005820:Genetic Testing / Q000379:methods* / Q000592:standards; D006801:Humans; D008661:Metabolism, Inborn Errors / Q000175:diagnosis* / Q000652:urine; D013057:Spectrum Analysis
D003287:Contrast Media